OMX Copenhagen 20 998018
8’832.20
Pkt
-109.10
Pkt
-1.22
%
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Copenhagen 20-Werten
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Halten | DZ BANK | |
| 06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.25 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 07.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. |